Regarding the Influence of Adjuvant Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarction: How Real Is the Risk?
- 20 November 2007
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (33) , 5325-5326
- https://doi.org/10.1200/jco.2007.13.9931
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial InfarctionsJournal of Clinical Oncology, 2007
- Radiotherapy in the Management of Clinically Localized Prostate Cancer: Evolving Standards, Consensus, Controversies and New DirectionsJournal of Clinical Oncology, 2005
- Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413Journal of Clinical Oncology, 2003